<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Endocr Disord</journal-id><journal-title-group><journal-title>BMC Endocrine Disorders</journal-title></journal-title-group><issn pub-type="epub">1472-6823</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21696575</article-id><article-id pub-id-type="pmc">3146888</article-id><article-id pub-id-type="publisher-id">1472-6823-11-12</article-id><article-id pub-id-type="doi">10.1186/1472-6823-11-12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Shab-Bidar</surname><given-names>Sakineh</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>s_shabbidar@razi.tums.ac.ir</email></contrib><contrib contrib-type="author" corresp="yes" id="A2"><name><surname>Neyestani</surname><given-names>Tirang R</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>neytr@yahoo.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A3"><name><surname>Djazayery</surname><given-names>Abolghassem</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jazaiers@sina.tums.ac.ir</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran</aff><aff id="I2"><label>2</label>Laboratory of Nutrition Research, National Research Institute and Faculty of Nutrition and Food Technology; Shahid Beheshti University of Medical Sciences (SBUM), Tehran, Iran</aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>22</day><month>6</month><year>2011</year></pub-date><volume>11</volume><fpage>12</fpage><lpage>12</lpage><history><date date-type="received"><day>24</day><month>3</month><year>2011</year></date><date date-type="accepted"><day>22</day><month>6</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2011 Shab-Bidar et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Shab-Bidar et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1472-6823/11/12"/><abstract><sec><title>Background</title><p>Development of type 2 diabetes mellitus (T2DM) is determined by the interactions of genetic and environmental factors. This study was designed to evaluate the possible role of VDR single nucleotide polymorphisms (SNPs) on different aspects of diabetic host response (anthropometric, metabolic, oxidative stress and inflammatory) to daily intake of vitamin D through fortified yogurt drink for 12 weeks.</p></sec><sec><title>Methods/Design</title><p>This study comprises two parts: (i) a case-control study; and (ii) an intervention trial. In the first part, VDR polymorphisms <italic>(Taq1</italic>, <italic>FokI</italic>, <italic>Apa1</italic>, <italic>Bsm1</italic>, and <italic>Cdx2) </italic>are determined in 350 T2DM patients and 350 non-diabetic subjects. In the second part, the possible effects of daily intake of two servings of vitamin D3-fortified yogurt drink (FYD; 500 IU vitamin D/250 mL) on some selected metabolic (including insulin resistance), inflammatory and oxidative stress biomarkers in 135 T2DM patients are assessed. To relate the resulted changes in the biomarkers to vitamin D replenishment, another group of diabetic patients (n = 45) are also included in the study who receive 2 servings of plain yogurt drink (PYD) a day. The primary outcome is serum level of 25(OH) D, which it is expected to be elevated only in FYD group. Secondary outcomes include improvements in glycemic, metabolic, inflammatory and oxidative stress biomarkers in FYD group compared to PYD group. Three VDR <italic>FokI </italic>polymorphisms are determined only in FYD group followed by comparison of changes in the biomarkers among these genotypic variants.</p></sec><sec><title>Discussion</title><p>The present study, at least in part, elucidates the discrepancies in the results of different vitamin D-diabetes studies pertaining to the genetic variations of the population. If VDR polymorphisms are found to influence the response to our intervention, then knowing distribution of VDR polymorphisms in both diabetic and non-diabetic populations can give a picture of the proportion of the community in whom up to 1000 IU/d vitamin D may not be effective enough to improve insulin resistance and related morbidities. Therefore, they should ideally receive further nutritional support according to their genotype.</p></sec><sec><title>Trial Registration</title><p>ClinicalTrials.gov: <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01236846">NCT01236846</ext-link></p></sec></abstract><kwd-group><kwd>vitamin D</kwd><kwd>vitamin D receptor</kwd><kwd>polymorphism</kwd><kwd>type 2 diabetes</kwd><kwd>study protocol</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Type 2 diabetes mellitus (T2DM) is a global epidemic costly condition [<xref ref-type="bibr" rid="B1">1</xref>]. Individuals with diabetes sustain reduction in quality of life, and high prevalence of mortality [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>Development of T2DM is determined by the interactions of genetic and environmental factors [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Most, if not all, genetic influences have a polymorphic nature [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. A number of loci have been studied so far to explain the genetic susceptibility to T2DM. An Example is genes associated with glucokinase, hepatocyte nuclear factors, insulin promoter factors, possibly the insulin and insulin receptor genes and mitochondrial genes [<xref ref-type="bibr" rid="B7">7</xref>]. Among interesting, and less studied, diabetes-related genes are those associated with vitamin D metabolism.</p><p>Apart from its calcemic effects, vitamin D is now known to have many non-calcemic functions through which it may have some role in several human pathologies including some forms of cancers [<xref ref-type="bibr" rid="B8">8</xref>], autoimmune disorders [<xref ref-type="bibr" rid="B9">9</xref>], obesity [<xref ref-type="bibr" rid="B10">10</xref>], metabolic syndrome [<xref ref-type="bibr" rid="B11">11</xref>] and both types 1 and 2 diabetes [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], among the others. Animal studies have shown impaired insulin secretion [<xref ref-type="bibr" rid="B14">14</xref>] and action [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] in vitamin D deficiency. Though vitamin D replenishment of type 2 diabetics has been shown to improve inflammatory biomarkers and glycemic control [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B23">23</xref>], some studies failed to demonstrate these beneficial effects [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The reasons for these discrepancies in results could be numerous including sample size, duration and mode of intervention (supplementation, injection, fortification, or...) and dosages used, baseline values of 25(OH)D and also of the other variables (glucose, lipids and so on), method of vitamin D assessment (RIA, CPBA, CL or HPLC) and finally genetic makeup of the study population.</p><p>The active form of vitamin D acts through a specific vitamin D receptor (VDR) [<xref ref-type="bibr" rid="B26">26</xref>]. Allelic differences in the VDR gene may contribute to the genetic predisposition to certain diseases [<xref ref-type="bibr" rid="B10">10</xref>]. Research findings on associations among VDR polymorphisms, vitamin D stats, T2DM and glycemic status have not been unanimous; some confirmed such relations [<xref ref-type="bibr" rid="B18">18</xref>] and some did not [<xref ref-type="bibr" rid="B25">25</xref>]. Nevertheless, as VDR has been recently found on pancreatic beta cells [<xref ref-type="bibr" rid="B24">24</xref>], it is plausible that genetic variants of the VDR gene may contribute to the development of T2DM. There is a mere paucity of controlled clinical trials on vitamin D and T2DM. On the other hand, the findings of a few trials have been inconsistent. Those studies mostly used either vitamin D injection (monthly or weekly high dose injection) [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>] or supplements [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>] (usually with dosages less than the amount believed to be sufficient [<xref ref-type="bibr" rid="B31">31</xref>]). In the present study we are going to use yogurt drink, which is an Iranian drink (Persian name: Doogh), for vitamin D fortification. Using fortified foodstuffs have the advantage of lower cost and higher compliance [<xref ref-type="bibr" rid="B32">32</xref>]. Considering the common nature of T2DM with obesity-induced insulin resistance and metabolic syndrome [<xref ref-type="bibr" rid="B33">33</xref>], two conditions with growing occurrence which may lead to T2DM [<xref ref-type="bibr" rid="B34">34</xref>], using vitamin D3-fortified yogurt drink, if proved to be effective in this study, can be encouraged as a preventive tool. This idea must be substantiated by further cohort studies.</p><p>This study was designed to evaluate the possible role of VDR single nucleotide polymorphisms (SNPs) on different aspects of diabetic host response (anthropometric, metabolic, oxidative stress and inflammatory) to daily intake of vitamin D through fortified yogurt drink for 12 weeks.</p></sec><sec><title>Specific Aims</title><p>This study comprises two parts. The first part aims to quantify the magnitude of association between any identified variants of the VDR gene and T2DM. A cross-sectional study is employed to compare distribution of each genotype of VDR polymorphisms in 350 type 2 diabetic adults and 350 non-diabetic controls. The second part is outlined to compare within- and between-polymorphic group variations of host response to daily intake of vitamin-D3-fortified yogurt drink in terms of anthropometric, metabolic, inflammatory and oxidative stress markers.</p><sec><title>Part 1</title><sec><title>Primary Objectives</title><p>To determine distribution of VDR gene polymorphism genotypes (<italic>Taq1</italic>, <italic>FokI</italic>, <italic>apa1</italic>, <italic>Bsm1</italic>, <italic>Cdx1</italic>) in T2DM patients and non-diabetic volunteers and to compare between these two groups</p></sec><sec><title>Secondary Objectives</title><p>To determine distribution of VDR gene polymorphism haplotypes (<italic>Taq1, FokI, Apa1, Bsm1, Cdx2</italic>) in T2DM patients and non-diabetic controls and to compare between these two groups</p></sec></sec><sec><title>Hypothesis</title><p>(i) There is a difference in prevalence of vitamin D receptor gene polymorphisms between diabetics and non-diabetic controls</p><p>(ii) There is a difference in prevalence of vitamin D receptor gene polymorphism haplotypes between diabetics and non-diabetic controls</p></sec><sec><title>Part 2 study</title><sec><title>Primary Objectives</title><p>To compare within- and between-polymorphic group variations in circulating 25(OH)D in diabetic subjects and also between diabetics and non-diabetic subjects.</p></sec><sec><title>Secondary objectives</title><p>(i) To compare within- and between-polymorphic group variations in anthropometric, metabolic, inflammatory and oxidative stress biomarkers</p><p>(ii) To conduct an exploratory analysis of changes in mean of anthropometric, metabolic, inflammatory and oxidative stress biomarkers in FYD group among sub-groups defined by genotypes of each VDR polymorphisms.</p></sec></sec><sec><title>Hypothesis</title><p>(i) Daily consumption of vitamin D3-fortified-yogurt drink improves serum 25(OH)D in type 2 diabetic patients.</p><p>(ii) Daily consumption of vitamin D3-fortified-yogurt drink improves biomarkers of anthropometric, metabolic, inflammatory and oxidative stress in type 2 diabetes patients.</p><p>(iii) Response to daily consumption of vitamin-D3-fortified yogurt drink differ between VDR polymorphic variant groups</p></sec></sec><sec><title>Methods/Design</title><sec><title>Part 1</title><sec><title>Participants</title><p>A case-control study is designed to compare VDR gene polymorphism distribution between T2DM and age-, sex- and body mass index (BMI)-matched non-diabetic subjects. T2DM patients are recruited from two centers; Iranian Diabetes Society and Gabric Diabetes Society, both located in Tehran. Diabetic subjects are recruited either by attending the classes held at the two centers and verbal invitation or through phone call. Non-diabetic controls are enrolled from school teachers, workers of Tehran or Shahid Beheshti Universities and Pegah Dairy Companies, all located in Tehran.</p><p>Full information on the study design and objectives of the study is given to all participants before they sign an informed written consent.</p></sec><sec><title>Sample Size</title><p>For observational study the sample size needed to obtain 90% power at a 5% significance level with an equal number of case and controls for the chi-square test on genotypes, is 350 at each group of cases and controls. The sample size is calculated using the software Quanto: <ext-link ext-link-type="uri" xlink:href="http://hydra.usc.edu/gxe/">http://hydra.usc.edu/gxe/</ext-link>.</p></sec><sec><title>Blood sampling</title><p>Fasting venous blood samples are collected into tubes either with or without anticoagulant (ethylene diamine tetra-acetate, EDTA). The anticoagulated tube is used to extract genomic DNA while the sera from clot samples are analyzed for glucose and lipids. Further information about blood sampling and genotyping are in part 2 study in detail.</p></sec><sec><title>Variables</title><p>Information on demographic, medical history, physical activity, duration of direct sun exposure and smoking habits are gathered using questionnaires and face-to-face interview. Anthropometric measures are taken in the same meeting. Table <xref ref-type="table" rid="T1">1</xref> shows the study variables.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Study measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Methods</th></tr></thead><tbody><tr><td align="left" colspan="2"><bold><italic>General data</italic></bold></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Demographic data</bold></td><td align="left">Questionnaire</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Medical history</bold></td><td align="left">Questionnaire</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Sun exposure</bold></td><td align="left">Questionnaire</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left" colspan="2"><bold><italic>Anthropometric and clinical data</italic></bold></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Height, weight, waist and hip circumference</bold></td><td align="left">Stadiometer, digital scale (Seca 840, Germany)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Blood pressure</bold></td><td align="left">A digital sphygmomanometer (BC08, Beurer, Germany).</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left" colspan="2"><bold><italic>Blood data</italic></bold></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Fasting plasma glucose, lipid profile</bold></td><td align="left">Pars Azmoon, Tehran, Iran</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>Complete blood cell count</bold></td><td align="left">Mythic, Orphe'e, France</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left"><bold>VDR gene polymorphisms</bold></td><td align="left">PCR-RFLP, Corbett Rotor-Gene 6000 instrument (Corbett Life Science)</td></tr></tbody></table></table-wrap></sec><sec><title>Value of results</title><p>This is the first study on the distribution of VDR SNPs among type 2 diabetics and their possible relations to the particular phenotypes in Iran. These data assist both to the better understanding of vitamin D-T2DM inter-relationships and to the preventive programs.</p></sec></sec><sec><title>Part 2</title><p>This is a 3-month randomized controlled clinical trial (RCT) in which T2DM patients aged 30-60 years are enrolled. The study design is presented in Figure <xref ref-type="fig" rid="F1">1</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>A summary of the interventional study</bold>.</p></caption><graphic xlink:href="1472-6823-11-12-1"/></fig><sec><title>Setting</title><p>The possible effects of daily intake of two servings of vitamin D3-fortified yogurt drink on some selected metabolic (including insulin resistance), inflammatory and oxidative stress biomarkers in T2DM patients (n = 135) are assessed. To relate the resulted changes in the biomarkers to vitamin D replenishment, another smaller group of diabetic patients (n = 45) are also included in the study who receive 2 servings of plain yogurt drink a day. To minimize endogenous vitamin D synthesis, the entire intervention is confined to cold seasons (fall and winter) of the year. The RCT is conducted collaboratively by National Nutrition and Food Technology Research Institute (NNFTRI) and Tehran University of Medical Sciences (TUMS) in Tehran, the capital of Iran.</p></sec><sec><title>Participants</title><p>T2DM patients are recruited from Iranian Diabetes Society or Gabric Diabetes Society as described in the first part of the study. Volunteers are invited to attend Laboratory of Nutrition Research at NNFTRI while they are fasting. Data gathering, bleeding and urine sampling all are done during 07.30 and 10.00 am.</p></sec><sec><title>Inclusion criteria</title><p>1. Having type 2 diabetes</p><p>2. Willingness to participate</p><p>3. BMI between 25 to 35 kg/m<sup>2</sup></p><p>4. Age: 30-60 years old</p><p>5. No use of any vitamin, dietary, herbal or omega-3 supplements since at least 3 months to and during the intervention period</p></sec><sec><title>Exclusion criteria</title><p>1. History of cardiovascular, gastrointestinal, renal, and other endocrinological diseases</p><p>2. Subjects receiving vitamin D, omega-3 or other types of dietary supplements</p><p>3. Pregnancy or lactation</p><p>4. Treatment with insulin</p><p>5. Treatment for weight reduction</p><p>6. Treatment for reducing serum cholesterol</p></sec><sec><title>Sample Size</title><p>Based on data on serum 25(OH)D changes from other studies [<xref ref-type="bibr" rid="B35">35</xref>], to achieve 1 standard deviation difference in circulating 25(OH)D with two-sided alpha of 0.05 and a beta of 0.2 after a 12-week intervention period, the sample size was calculated 40 individuals per treatment group. Considering 3 polymorphic variant groups and one control group which receives plain yogurt drink, 160 subjects are needed. Allowing for 10% attrition over 12 weeks of intervention, a total of 180 subjects are required.</p></sec><sec><title>Run-in</title><p>On the first visit and following completion of the questionnaires, all participants are given some general information on diabetic diet, based on American Dietetic Association (ADA) guidelines [<xref ref-type="bibr" rid="B36">36</xref>], with special focus on fruits, vegetables and dairy intakes. Patients are instructed not to change their usual physical activity and to include 2-3 exchanges of fruits, 2 exchanges of vegetables and 2-3 exchanges of low-fat milk exchanges in their daily diet for the next 2 weeks (run in period).</p></sec><sec><title>Randomization/Blinding</title><p>After run-in period, participants are assigned randomly to one of the treatment groups of either fortified yogurt drink (FYD, n<sub>1 </sub>= 135) or plain yogurt drink (PYD, n<sub>2 </sub>= 45) using permuted blocks of random numbers allocation method. Letter codes A and B are used to identify two groups, respectively. Yogurt drinks are identical in color, size, taste and packaging. Therefore, participants are not aware of their group, neither are all the interviewers and laboratory staff. However, the main investigators could not be technically blind to the identity of the letter codes.</p><p>The randomization and labeling process are audited halfway through the study by an observer to find if it is robust, accurate and able to maintain blinding of participants.</p></sec><sec><title>Intervention</title><p>Yogurt drinks are either plain (PYD; containing 170 mg calcium and no vitamin D/250 mL) or vitamin D<sub>3</sub>-fortified (FYD; containing 170 mg calcium and 500 IU vitamin D<sub>3</sub>/250 mL). Participants are instructed to consume a bottle of yogurt drink with both lunch and dinner, i.e. 500 mL/d equaling 1000 IU vitamin D<sub>3 </sub>a day in FYD group. The intervention period is 12 weeks. Consumption of 1000 IU/d vitamin D is believed to be safe and effective to increase circulating 25(OH)D [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Participants are given yogurt drinks in 30-bottle packs, which are enough for 2 weeks. All subjects are visited biweekly to both assess their compliance and provide them with yogurt drinks for the next two weeks. Blood pressure, anthropometric, dietary, body fat and laboratory evaluations are preformed both before and after intervention. Data comparison are made between PYD and FYD groups and also, in FYD group, among VDR polymorphic groups.</p></sec><sec><title>Compliance</title><p>All participants are given a pamphlet on "instructions to use yogurt drinks" together with a "yogurt drink consumption table" comprised of 28 empty boxes for each week. Subjects are instructed to mount the table in an exposed place (preferably on refrigerator) and to tick each box after consumption a yogurt drink with each meal. Moreover, they are asked to bring the empty bottles back on their next visit. Compliance is evaluated by checking the consumption tables, counting the empty bottles, direct enquiry both on the biweekly visits and weekly follow-up phone calls.</p></sec><sec><title>Quality control of product</title><p>Composition (including vitamin D<sub>3</sub>) of the yogurt drinks are measured right after production, in the middle and end of the storage, to ensure the stability of the components, especially vitamin D, in the product. The measurements are done by Maad Laboratory of Foods, Drinks and Cosmetics, accredited by the Deputy of Food and Drug of the Iranian Ministry of Health.</p></sec><sec><title>Outcome Measurements</title><sec><title>Dietary assessment</title><p>A semi-quantitative Food Frequency Questionnaire (sqFFQ) and 24-h dietary recall for 3 days (including a weekend day) are used for assessment of dietary intake.</p></sec><sec><title>Anthropometry and Blood Pressure</title><p>Body weight is measured with light clothes without shoes using a digital scale (Seca 808, Germany) to the nearest of 0.1 kg. Height is measured using a stadiometer (Seca, Germany) to the nearest of 0.1 cm. BMI is calculated by dividing weight (kg) per height (m) square. Waist circumference (WC) is measured in the midpoint of the lowest rib and iliac crest in the end of expiration using a measuring tape to the nearest of 0.1 cm</p><p>To measure blood pressure (BP), subjects are allowed to be in sitting position at least 10 minutes. BP is measured twice by a digital sphygmomanometer (BC08, Beurer, Germany). The average of the two measurements is considered as subject's BP.</p></sec><sec><title>Body Composition Analysis</title><p>The percentage of body fat is evaluated using bioelectrical impedance analysis (Quadscan 4000 system, Bodystat, UK).</p></sec></sec></sec><sec><title>Laboratory investigations</title><p>All laboratory analyses are performed at the Laboratory of Nutrition Research, NNFTRI.</p><sec><title>Blood sampling and handling</title><p>Twenty mL of fasting venous blood taken from all participants by phlebotomy is divided in three tubes: (i) a micotube with an anticoagulant, EDTA; (ii) a heparinized 15-mL sterile capped plastic tube; and (iii) a clean glass test tube without anticoagulant. Of about 500 &#x003bc;L EDTA-blood sample in the microtube, 9 &#x003bc;L is used for CBC. Heparinized blood sample is used for PBMC separation and culture while the clot blood samples are kept for ~30 at RT followed by centrifugation at 1500 <italic>g </italic>at RT. Sera thus recovered are transferred to clean micro-tubes in aliquots. One aliquot is used to determine fasting serum glucose (FSG) and lipid profile in the same day of bleeding while the other tubes are kept at -80&#x000b0;C until the day of analysis.</p></sec><sec><title>Hemoglobin and hematocrit</title><p>Hemoglobin and hematocrit are measured as parts of complete blood cell count (CBC) test in the same day of blood sampling by a cell-counter system (Mythic, Orphee, France).</p></sec></sec><sec><title>Blood chemistry</title><p>Fasting serum glucose (FSG), lipid profile including triglycerides (TG), total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and uric acid are determined using enzymatic methods. Serum total protein, albumin, calcium, phosphorous and magnesium are measured by colorimetric assays. All these tests are done by commercial kits (all from Pars Azmoon, Iran) using an auto-analyzer system (Selectra E, Vitalab, the Netherlands).</p><p>Glycated hemoglobin (HbA1c) is determined using colorometric method after an initial chromatographic separation (BioSystems, Spain).</p><p>Serum insulin levels are measured by immunoradiometric assay (IRMA) using a commercial kit (Biosource, Belgium) and a &#x003b3;-counter system (Gamma I, Genesys, USA).</p><p>Insulin resistance is evaluated by Quantitative Insulin Check Index (QUICKI) calculated as [<xref ref-type="bibr" rid="B39">39</xref>]:</p><p>QUICKI: 1/[log (insulin) (&#x003bc;U/mL) + log (glucose) (mg/dL)]</p><p>Serum 25(OH)D concentrations are measured by HPLC method as described elsewhere [<xref ref-type="bibr" rid="B40">40</xref>]. Serum intact parathyroid hormone (iPTH) (DRG, Germany) and osteocalcin (Biousource, Belgium) concentrations are determined using enzyme immunoassay (EIA).</p><p>In this study oxidative stress is evaluated by determination of serum glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase (all from Bender Medsystems, Austria), total antioxidant capacity (TAC) using colorometic method with ABTS reagent and bovine serum albumin as standard, as reported earlier [<xref ref-type="bibr" rid="B41">41</xref>] and malondialdehyde (MDA), as described originally [<xref ref-type="bibr" rid="B42">42</xref>] with some modifications [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Inflammatory status is evaluated using determination of highly sensitive C-reactive protein (hsCRP) (immunoturbidometric assay, Pars Azmoon, Iran), serum amyloid A (SAA), endothelin-1 (both from IBL, Germany), E-selectin and matrix metalloproteinase (MMP)-9 (both from e-Bioscience, Austeria).</p></sec><sec><title>Urinary tests</title><p>Urinary sodium and potassium are measured by flame photometry (Corning 480; Corning Ltd, Halstead, Essex, UK). Urinary albumin and Creatinine are determined by immunoturbidometric and colorometic methods, respectively (both from Pars Azmoon, Iran) with the aid of an auto-analyzer (Selectra E, Vitalab, the Netherlands).</p><sec><title>PBMCs culture</title><p>Peripheral blood mononuclear cells (PBMC) were separated using Ficoll-hypaque gradient density centrifugation and cultured as described elsewhere [<xref ref-type="bibr" rid="B44">44</xref>] with minor modifications. In this study, ~10<sup>6 </sup>cells are transferred to a culture well in a 6-well cell culture plate (Greiner bio-one, Germany), each well containing 1% phytohemmaglutinin (PHA) (Gibco), 100 ng/mL lipopolysaccharide (LPS) (Gibco), 100 U/mL penicillin G and 10 ng/mL streptomycin (both from Sigma-Aldrich) in a total volume of 2 mL RPMI 1640. PBMC culture is performed in triplicate.</p></sec><sec><title>Cytokine assay</title><p>Concentrations of interleukin (IL)-2, IL-4, IL-6, IL-10 and tumor necrosis factor (TNF)-&#x003b1; (all from Bender Medsystems, Austria) are determined in PBMCs culture supernatant. All EIA tests are performed with the aid of a microplate reader (Statfax 3200, Awareness, USA).</p></sec></sec><sec><title>DNA extraction</title><p>Whole blood collected in a microtube containing 20 &#x003bc;L 7% EDTA are processed using Genet Bio DNA Isolation Kit (PrimePrepth, South Korea) following the procedures detailed in the kit to extract genomic DNA. Stock DNA is stored at -20 in a linked anonymized format, with codes held by principal investigators.</p></sec><sec><title>DNA genotyping</title><p>The VDR genotypes at <italic>BsmI, TaqI, ApaI, FokI </italic>and <italic>Cdx-2 </italic>SNP sites are determined using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) analysis as described below. We use a gradient palm-cycler (Corbett Research, Australia) for PCR amplification. The purified primers (Fermentase) and Premixes (Cinnagen) are purchased. Specific primers are selected and validated for SNPs (table <xref ref-type="table" rid="T2">2</xref>) [<xref ref-type="bibr" rid="B45">45</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. We use BLAST search (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST">http://www.ncbi.nlm.nih.gov/BLAST</ext-link>) to check the specificities and homology percent of primers for the VDR sequence. All primers show 99% homology to the sequence in specific region of the VDR gene.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>VDR polymorphisms and PCR-RFLP information</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SNP</th><th align="left">Localization</th><th align="left">Base change</th><th align="left">Nomenclature</th><th align="left">Forward primer/reverse primer</th><th align="left">Amplicone</th><th align="left">Restriction site</th><th align="left">Digestion fragments</th><th align="left">Genotype</th><th align="left">Restriction enzyme</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left"><bold><italic>FokI</italic></bold></td><td align="left">Exon 2</td><td align="left">C/T</td><td align="left">FF<break/>Ff<break/>ff</td><td align="left">5'-AgC Tgg CCC Tgg CAC TgA CTC TgC TCT-3'<break/>5'-ATg gAA ACA CCT TgC TTC TTC TCC CTC-3'</td><td align="left">265</td><td align="left">CC<break/>CT<break/>TT</td><td align="left">207-60</td><td align="left">mut<break/>ht<break/>wt</td><td align="left">FokI</td><td align="left">[<xref ref-type="bibr" rid="B45">45</xref>]</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td align="left"><bold><italic>BsmI</italic></bold></td><td align="left">Intron 8</td><td align="left">G/A</td><td align="left">BB<break/>Bb<break/>bb</td><td align="left">5'-ggC AAC CTg AAg ggA gAC gTA-3'<break/>5'-CTC TTT ggA CCT CAT CAC CgA C-3'</td><td align="left">461</td><td align="left">AA<break/>GA<break/>GG</td><td align="left">258-253</td><td align="left">mut<break/>ht<break/>wt</td><td align="left">Mva 1269I</td><td align="left">[<xref ref-type="bibr" rid="B46">46</xref>]</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td align="left"><bold><italic>TaqI</italic></bold></td><td align="left">Exon 9</td><td align="left">T/C</td><td align="left">TT<break/>Tt<break/>tt</td><td align="left">5'-CAg AgC ATg gAC Agg gAg CAA g-3'<break/>5'-gCA ACT CCT CAT ggC TgA ggT CTC A-3'</td><td align="left">740</td><td align="left">TT<break/>TC<break/>CC</td><td align="left">495-245-290-205</td><td align="left">wt<break/>ht<break/>mut</td><td align="left">TaqI</td><td align="left">[<xref ref-type="bibr" rid="B45">45</xref>]</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td align="left"><bold><italic>ApaI</italic></bold></td><td align="left">Intron 8</td><td align="left">G/T</td><td align="left">AA<break/>Aa<break/>aa</td><td align="left">5'-CAg AgC ATg gAC Agg gAg CAA g-3'<break/>5'-gCA ACT CCT CAT ggC TgA ggT CTC A-3'</td><td align="left">740</td><td align="left">TT<break/>GT<break/>GG</td><td align="left">515-225</td><td align="left">mut<break/>ht<break/>wt</td><td align="left">Bsp120I</td><td align="left">[<xref ref-type="bibr" rid="B45">45</xref>]</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td align="left"><bold><italic>Cdx-2</italic></bold></td><td align="left">Intron 1e</td><td align="left">G/A</td><td align="left">CC<break/>Cc<break/>cc</td><td align="left">5'-CAg CAT gCC TgT CCT CAg C-3'<break/>5'-CCA gTA CTg CCA gCT CCC-3'</td><td align="left">250</td><td align="left">AA<break/>GA<break/>GG</td><td/><td align="left">mut<break/>ht<break/>wt</td><td align="left">Bpu10I</td><td align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td></tr></tbody></table></table-wrap></sec><sec><title>Data management</title><p>For the better quality and accuracy of data, real time data entry is ensured. We use manual checking of frequencies during data entry. For primary analysis, alphabetical codes for groups are used still blinded to the real group identity.</p></sec><sec><title>Statistical analyses</title><p>Data are expressed as mean &#x000b1; SD. Normality of data distribution is evaluated using Kolmogrov-Smirnov. Comparison of data between two groups is done by either student <italic>t </italic>test (normal distribution) or Mann-Whitney U (not normal distribution).</p><p>Genotype distribution of the 5 VDR SNPs in the study population is evaluated for Hardy-Weinberg equilibrium by Chi square test. Odds ratios (OR) are given with 95% confidence intervals (CI). Haplotypes frequencies and distributions are estimated with a program based on EH (estimating haplotypes)[<xref ref-type="bibr" rid="B48">48</xref>]. Haplotypes are compiled as combinations of the 3 SNPs (<italic>BsmI</italic>, <italic>TaqI</italic>, <italic>ApaI</italic>).</p><p>The differences in distribution of the biomarkers among polymorphic variant groups are compared by analysis of variance (ANOVA) and, in the case of significant difference, Tukey's post hoc analysis. A p value &#x0003c; 0.05 is considered significant. Correlation between two sets of data is evaluated using either Pearson (normal distribution) or Spearman (not normal distribution) equations. Multiple linear regression modeling is used to identify the contributions of each independent variable to the variation of response to vitamin D supplementation.</p></sec><sec><title>Data Validation</title><p>Data cleaning takes place by a series of logical checks on the electronic data. Discrepant records are checked with the source documents and the database is amended, if necessary.</p></sec><sec><title>Ethical issues</title><p>The study protocol has been approved by the NNFTRI (No. 035360), Shahid Beheshti University of Medical Science, and by Tehran University of Medical Sciences (TUMS) (No.10533) Ethical committees.</p></sec></sec><sec><title>Discussion</title><p>Increasing evidences suggest a pivotal role for vitamin D in insulin action [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] and T2DM [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. However, the results of vitamin D supplementation in diabetics have not been consistent [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The reasons for this inconsistency could be the vitamin D dosage and route of administration (injection [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>] vs. oral [<xref ref-type="bibr" rid="B30">30</xref>]), age of the study population (middle aged [<xref ref-type="bibr" rid="B49">49</xref>] vs. elderly [<xref ref-type="bibr" rid="B50">50</xref>]) and probably genetic variations. The role of VDR polymorphism in response to vitamin D interventions has been reported in other clinical settings [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. The contribution of VDR polymorphism in susceptibility to T2DM has also been shown in some studies recently [<xref ref-type="bibr" rid="B18">18</xref>]. However, this is the first clinical trial on the role of VDR polymorphism in response to vitamin D replenishment on different aspects of diabetic pathology, including anthropometric, metabolic, oxidative stress, inflammatory and immunity. This study pursues three objectives: Firstly, to tackle relationship between VDR genotypes and T2DM for the first time in Iranian population; secondly, to elucidate the potential mechanisms and cross-talk among pathways, by which vitamin D exerts its effects on diabetes, insulin resistance and cardiovascular disease by evaluating an extensive panel of biomarkers (anthropometric, metabolic, inflammatory and oxidative stress); and finally to identify vitamin D responsive vs. less or (maybe) non-responsive VDR genetic variants in subjects with T2DM for further proper nutritional care.</p><p>The following points can be considered as the strengths of this study: i) the intervention is conducted during cold seasons, when dermal synthesis, especially at Tehran latitude, is minimal[<xref ref-type="bibr" rid="B53">53</xref>]; ii) various degrees of vitamin D deficiency have been shown to be prevalent in Iranian general population at almost all ages [<xref ref-type="bibr" rid="B54">54</xref>] as well as diabetics [<xref ref-type="bibr" rid="B21">21</xref>]. Because of lower basal 25(OH)D levels, the response to vitamin D replenishment is expected to be more prominent; iii) yogurt drink, a popular Iranian drink, is used to fortify with vitamin D for the first time. The results of this study will show the bioavailability of vitamin D in this drink. Moreover, apart from the added vitamin D, yogurt drink protein and calcium content makes it a very good choice and a substitute for sugar-free colas and even juices in diabetic, as well as a variety of non-diabetic, diets; iv) the dosage of vitamin D [<xref ref-type="bibr" rid="B55">55</xref>] and duration of intervention [<xref ref-type="bibr" rid="B56">56</xref>] seem to be proper.</p><p>The present study, at least in part, elucidates the discrepancies in the results of different vitamin D-diabetes studies pertaining to the genetic variations of the population. On the other hand, the importance of the upcoming results lies on the fact that both metabolic syndrome and obesity-induced insulin resistance, two conditions with increasing global occurrences which predispose T2DM development [<xref ref-type="bibr" rid="B33">33</xref>], have similar pathologic bases [<xref ref-type="bibr" rid="B34">34</xref>]. If VDR SNPs are found to influence the response to our intervention, then knowing distribution of VDR polymorphisms in both diabetic and non-diabetic populations can give a picture of the proportion of the community in whom up to 1000 IU/d vitamin D may not be effective enough to improve insulin resistance and related morbidities. Therefore, they should ideally receive further nutritional support according to their genotype.</p></sec><sec><title>Abbreviations</title><p>BLAST: basic local alignment search tool; BP: blood pressure; BMI: body mass index; CVD: cardiovascular disease; CL: chemiluminesence; CPBA: competitive protein binding assay; DNA: deoxyribonucleic acid; EIA: enzyme linked immune assay; EDTA: ethylene diamine tetra-acetate; FSG: fasting serum glucose; FYD: fortified yogurt drink; HDL-C: high density cholesterol; ht: heterozygote mutated; HPLC: high-performance liquid chromatography; hs-CRP: highly sensitive C-reactive protein; iPTH: intact parathyroid hormone; IFN-gamma: Interferon-gamma; IL-4/IL-10/IL-6/IL-2: Interleukin 4/Interleukin 10/Interleukin-6/Interleukin-2; LPS: lipopolysaccharide; LDL-C: low density lipoprotein cholesterol; MDA: malondialdeyde; mut: homozygote mutated; NNFTRI: national nutrition and food technology research institute; PHA: phytohemmaglutinin; PYD: plain yogurt drink; PCR: polymerase chain reaction; RIA: radioimmunoassay; RCT: randomized clinical trial; RFLP: restriction fragment length polymorphism; sqFFQ: semi-quantitative Food Frequency Questionnaire; SNP: single nucleotide polymorphism; TUMS: Tehran University of medical sciences; TG: triglycerides; TNF: tumor necrosis factor; T2DM: type 2 diabetes mellitus; WC: waist circumference; Wt: homozygote wild type</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>TRN designed the initial idea of this work, which was further developed by SSh and ADj. Now, this is a common project between NNFTRI and TUMS, the most part of which is being done as Ph.D. research of SSh under the supervision of both TRN and ADj. The manuscript has been read and approved by all authors.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6823/11/12/prepub">http://www.biomedcentral.com/1472-6823/11/12/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>We thank the Iranian Diabetic Society and Gabric Diabetic society for their collaborations. They have no role in study design, data collection, synthesis and interpretation, writing the report, or the decision to submit the manuscript for publication. This study is funded by NNFTRI, TUMS and Iran National Science Foundation, in order of their financial contributions. INSF had no role in the study conception or design. Half of the yogurt drinks (both plain and vitamin D-fortified) was dedicated by Pegah Company to the researchers while the remainder was purchased from there.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="book"><article-title>Economic consequences of diabetes mellitus in the U.S. in 1997</article-title><source>Diabetes Care</source><year>1998</year><volume>21</volume><issue>2</issue><publisher-name>American Diabetes Association</publisher-name><fpage>296</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">9539999</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Narayan</surname><given-names>KM</given-names></name><name><surname>Boyle</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>TJ</given-names></name><name><surname>Sorensen</surname><given-names>SW</given-names></name><name><surname>Williamson</surname><given-names>DF</given-names></name><article-title>Lifetime risk for diabetes mellitus in the United States</article-title><source>Jama</source><year>2003</year><volume>290</volume><issue>14</issue><fpage>1884</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1001/jama.290.14.1884</pub-id><pub-id pub-id-type="pmid">14532317</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Hamman</surname><given-names>RF</given-names></name><article-title>Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)</article-title><source>Diabetes Metab Rev</source><year>1992</year><volume>8</volume><issue>4</issue><fpage>287</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1002/dmr.5610080402</pub-id><pub-id pub-id-type="pmid">1307522</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Patti</surname><given-names>ME</given-names></name><article-title>Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes</article-title><source>Clin Sci (Lond)</source><year>2009</year><volume>116</volume><issue>2</issue><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1042/CS20080090</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Gillies</surname><given-names>PJ</given-names></name><article-title>Nutrigenomics: the Rubicon of molecular nutrition</article-title><source>J Am Diet Assoc</source><year>2003</year><volume>103</volume><issue>12 Suppl 2</issue><fpage>S50</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">14666500</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Fallin</surname><given-names>D</given-names></name><name><surname>Lanchbury</surname><given-names>JS</given-names></name><article-title>Single nucleotide polymorphisms and the future of genetic epidemiology</article-title><source>Clin Genet</source><year>2000</year><volume>58</volume><issue>4</issue><fpage>250</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">11076050</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Middelberg</surname><given-names>RP</given-names></name><name><surname>Harding</surname><given-names>AH</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Jakes</surname><given-names>RW</given-names></name><name><surname>Clayton</surname><given-names>D</given-names></name><name><surname>Schafer</surname><given-names>AJ</given-names></name><name><surname>O'Rahilly</surname><given-names>S</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><article-title>Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action</article-title><source>PLoS Biol</source><year>2003</year><volume>1</volume><issue>1</issue><fpage>E20</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0000020</pub-id><pub-id pub-id-type="pmid">14551916</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Krishnan</surname><given-names>AV</given-names></name><name><surname>Trump</surname><given-names>DL</given-names></name><name><surname>Johnson</surname><given-names>CS</given-names></name><name><surname>Feldman</surname><given-names>D</given-names></name><article-title>The role of vitamin D in cancer prevention and treatment</article-title><source>Endocrinol Metab Clin North Am</source><year>2010</year><volume>39</volume><issue>2</issue><fpage>401</fpage><lpage>418</lpage><comment>table of contents</comment><pub-id pub-id-type="doi">10.1016/j.ecl.2010.02.011</pub-id><pub-id pub-id-type="pmid">20511060</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Kamen</surname><given-names>DL</given-names></name><name><surname>Tangpricha</surname><given-names>V</given-names></name><article-title>Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity</article-title><source>J Mol Med</source><year>2010</year><volume>88</volume><issue>5</issue><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1007/s00109-010-0590-9</pub-id><pub-id pub-id-type="pmid">20119827</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Reis</surname><given-names>AF</given-names></name><name><surname>Hauache</surname><given-names>OM</given-names></name><name><surname>Velho</surname><given-names>G</given-names></name><article-title>Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence</article-title><source>Diabetes Metab</source><year>2005</year><volume>31</volume><issue>4 Pt 1</issue><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">16369193</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Martini</surname><given-names>LA</given-names></name><name><surname>Wood</surname><given-names>RJ</given-names></name><article-title>Vitamin D status and the metabolic syndrome</article-title><source>Nutr Rev</source><year>2006</year><volume>64</volume><issue>11</issue><fpage>479</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2006.tb00180.x</pub-id><pub-id pub-id-type="pmid">17131943</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Palomer</surname><given-names>X</given-names></name><name><surname>Gonzalez-Clemente</surname><given-names>JM</given-names></name><name><surname>Blanco-Vaca</surname><given-names>F</given-names></name><name><surname>Mauricio</surname><given-names>D</given-names></name><article-title>Role of vitamin D in the pathogenesis of type 2 diabetes mellitus</article-title><source>Diabetes Obes Metab</source><year>2008</year><volume>10</volume><issue>3</issue><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1111/j.1463-1326.2007.00710.x</pub-id><pub-id pub-id-type="pmid">18269634</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name><article-title>Vitamin D and type 1 diabetes mellitus: state of the art</article-title><source>Trends Endocrinol Metab</source><year>2005</year><volume>16</volume><issue>6</issue><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2005.06.004</pub-id><pub-id pub-id-type="pmid">15996876</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Gregori</surname><given-names>S</given-names></name><name><surname>Giarratana</surname><given-names>N</given-names></name><name><surname>Smiroldo</surname><given-names>S</given-names></name><name><surname>Uskokovic</surname><given-names>M</given-names></name><name><surname>Adorini</surname><given-names>L</given-names></name><article-title>A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><issue>5</issue><fpage>1367</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.5.1367</pub-id><pub-id pub-id-type="pmid">11978632</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Kadowaki</surname><given-names>S</given-names></name><name><surname>Norman</surname><given-names>AW</given-names></name><article-title>Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas</article-title><source>J Clin Invest</source><year>1984</year><volume>73</volume><issue>3</issue><fpage>759</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1172/JCI111269</pub-id><pub-id pub-id-type="pmid">6323527</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Gedik</surname><given-names>O</given-names></name><name><surname>Akalin</surname><given-names>S</given-names></name><article-title>Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man</article-title><source>Diabetologia</source><year>1986</year><volume>29</volume><issue>3</issue><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1007/BF02427083</pub-id><pub-id pub-id-type="pmid">3516771</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Avenell</surname><given-names>A</given-names></name><name><surname>Cook</surname><given-names>JA</given-names></name><name><surname>MacLennan</surname><given-names>GS</given-names></name><name><surname>McPherson</surname><given-names>GC</given-names></name><article-title>Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)</article-title><source>Age Ageing</source><year>2009</year><volume>38</volume><issue>5</issue><fpage>606</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1093/ageing/afp109</pub-id><pub-id pub-id-type="pmid">19617604</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Schwalfenberg</surname><given-names>G</given-names></name><article-title>Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion</article-title><source>Can Fam Physician</source><year>2008</year><volume>54</volume><issue>6</issue><fpage>864</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">18556494</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Schleithoff</surname><given-names>SS</given-names></name><name><surname>Zittermann</surname><given-names>A</given-names></name><name><surname>Tenderich</surname><given-names>G</given-names></name><name><surname>Berthold</surname><given-names>HK</given-names></name><name><surname>Stehle</surname><given-names>P</given-names></name><name><surname>Koerfer</surname><given-names>R</given-names></name><article-title>Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><issue>4</issue><fpage>754</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">16600924</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Pittas</surname><given-names>AG</given-names></name><name><surname>Harris</surname><given-names>SS</given-names></name><name><surname>Stark</surname><given-names>PC</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name><article-title>The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><issue>4</issue><fpage>980</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.2337/dc06-1994</pub-id><pub-id pub-id-type="pmid">17277040</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Neyestani</surname><given-names>T</given-names></name><name><surname>Gharavi</surname><given-names>A</given-names></name><name><surname>Kalayi</surname><given-names>A</given-names></name><article-title>Iranian diabetics may not be Vitamin D deficient more than healthy subjects</article-title><source>Acta Medica Iranica</source><year>2008</year><volume>46</volume><issue>4</issue></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Campbell</surname><given-names>IT</given-names></name><name><surname>Jarrett</surname><given-names>RJ</given-names></name><name><surname>Keen</surname><given-names>H</given-names></name><article-title>Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic</article-title><source>Diabetologia</source><year>1975</year><volume>11</volume><issue>2</issue><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1007/BF00429838</pub-id><pub-id pub-id-type="pmid">168108</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Gikas</surname><given-names>A</given-names></name><name><surname>Sotiropoulos</surname><given-names>A</given-names></name><name><surname>Pastromas</surname><given-names>V</given-names></name><name><surname>Papazafiropoulou</surname><given-names>A</given-names></name><name><surname>Apostolou</surname><given-names>O</given-names></name><name><surname>Pappas</surname><given-names>S</given-names></name><article-title>Seasonal variation in fasting glucose and HbA1c in patients with type 2 diabetes</article-title><source>Prim Care Diabetes</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.pcd.2009.05.004</pub-id><pub-id pub-id-type="pmid">19535310</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Parekh</surname><given-names>D</given-names></name><name><surname>Sarathi</surname><given-names>V</given-names></name><name><surname>Shivane</surname><given-names>VK</given-names></name><name><surname>Bandgar</surname><given-names>TR</given-names></name><name><surname>Menon</surname><given-names>PS</given-names></name><name><surname>Shah</surname><given-names>NS</given-names></name><article-title>Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus</article-title><source>Endocr Pract</source><year>2010</year><volume>16</volume><issue>4</issue><fpage>600</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.4158/EP09300.OR</pub-id><pub-id pub-id-type="pmid">20350923</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Poretsky</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>E</given-names></name><article-title>Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial</article-title><source>J Diabetes</source><year>2010</year><volume>2</volume><issue>1</issue><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/j.1753-0407.2009.00057.x</pub-id><pub-id pub-id-type="pmid">20923473</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Bid</surname><given-names>HK</given-names></name><name><surname>Konwar</surname><given-names>R</given-names></name><name><surname>Aggarwal</surname><given-names>CG</given-names></name><name><surname>Gautam</surname><given-names>S</given-names></name><name><surname>Saxena</surname><given-names>M</given-names></name><name><surname>Nayak</surname><given-names>VL</given-names></name><name><surname>Banerjee</surname><given-names>M</given-names></name><article-title>Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study</article-title><source>Indian J Med Sci</source><year>2009</year><volume>63</volume><issue>5</issue><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.4103/0019-5359.53164</pub-id><pub-id pub-id-type="pmid">19584489</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Boucher</surname><given-names>BJ</given-names></name><name><surname>Mannan</surname><given-names>N</given-names></name><name><surname>Noonan</surname><given-names>K</given-names></name><name><surname>Hales</surname><given-names>CN</given-names></name><name><surname>Evans</surname><given-names>SJ</given-names></name><article-title>Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians</article-title><source>Diabetologia</source><year>1995</year><volume>38</volume><issue>10</issue><fpage>1239</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1007/BF00422375</pub-id><pub-id pub-id-type="pmid">8690178</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AV</given-names></name><name><surname>Wise</surname><given-names>PH</given-names></name><article-title>Vitamin D replacement in Asians with diabetes may increase insulin resistance</article-title><source>Postgrad Med J</source><year>1998</year><volume>74</volume><issue>872</issue><fpage>365</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1136/pgmj.74.872.365</pub-id><pub-id pub-id-type="pmid">9799895</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Isaia</surname><given-names>G</given-names></name><name><surname>Giorgino</surname><given-names>R</given-names></name><name><surname>Adami</surname><given-names>S</given-names></name><article-title>High prevalence of hypovitaminosis D in female type 2 diabetic population</article-title><source>Diabetes Care</source><year>2001</year><volume>24</volume><issue>8</issue><fpage>1496.</fpage><pub-id pub-id-type="doi">10.2337/diacare.24.8.1496</pub-id><pub-id pub-id-type="pmid">11473093</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Borissova</surname><given-names>AM</given-names></name><name><surname>Tankova</surname><given-names>T</given-names></name><name><surname>Kirilov</surname><given-names>G</given-names></name><name><surname>Dakovska</surname><given-names>L</given-names></name><name><surname>Kovacheva</surname><given-names>R</given-names></name><article-title>The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients</article-title><source>Int J Clin Pract</source><year>2003</year><volume>57</volume><issue>4</issue><fpage>258</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">12800453</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Allegra</surname><given-names>V</given-names></name><name><surname>Luisetto</surname><given-names>G</given-names></name><name><surname>Mengozzi</surname><given-names>G</given-names></name><name><surname>Martimbianco</surname><given-names>L</given-names></name><name><surname>Vasile</surname><given-names>A</given-names></name><article-title>Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3</article-title><source>Nephron</source><year>1994</year><volume>68</volume><issue>1</issue><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1159/000188085</pub-id><pub-id pub-id-type="pmid">7991039</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Sadighi</surname><given-names>J</given-names></name><name><surname>Sheikholeslam</surname><given-names>R</given-names></name><name><surname>Mohammad</surname><given-names>K</given-names></name><name><surname>Pouraram</surname><given-names>H</given-names></name><name><surname>Abdollahi</surname><given-names>Z</given-names></name><name><surname>Samadpour</surname><given-names>K</given-names></name><name><surname>Kolahdooz</surname><given-names>F</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><article-title>Flour fortification with iron: a mid-term evaluation</article-title><source>Public Health</source><year>2008</year><volume>122</volume><issue>3</issue><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.puhe.2007.05.002</pub-id><pub-id pub-id-type="pmid">17645902</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="other"><name><surname>Nichols</surname><given-names>GA</given-names></name><name><surname>Moler</surname><given-names>EJ</given-names></name><article-title>Metabolic Syndrome Components Are Associated with Future Medical Costs Independent of Cardiovascular Hospitalization and Incident Diabetes</article-title><source>Metab Syndr Relat Disord</source><year>2010</year></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Halpern</surname><given-names>A</given-names></name><name><surname>Mancini</surname><given-names>MC</given-names></name><name><surname>Magalhaes</surname><given-names>ME</given-names></name><name><surname>Fisberg</surname><given-names>M</given-names></name><name><surname>Radominski</surname><given-names>R</given-names></name><name><surname>Bertolami</surname><given-names>MC</given-names></name><name><surname>Bertolami</surname><given-names>A</given-names></name><name><surname>de Melo</surname><given-names>ME</given-names></name><name><surname>Zanella</surname><given-names>MT</given-names></name><name><surname>Queiroz</surname><given-names>MS</given-names></name><etal/><article-title>Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment</article-title><source>Diabetol Metab Syndr</source><year>2010</year><volume>2</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/1758-5996-2-55</pub-id><pub-id pub-id-type="pmid">20718958</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Tangpricha</surname><given-names>V</given-names></name><name><surname>Koutkia</surname><given-names>P</given-names></name><name><surname>Rieke</surname><given-names>SM</given-names></name><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Perez</surname><given-names>AA</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><article-title>Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>77</volume><issue>6</issue><fpage>1478</fpage><lpage>1483</lpage><pub-id pub-id-type="pmid">12791627</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Bantle</surname><given-names>JP</given-names></name><name><surname>Wylie-Rosett</surname><given-names>J</given-names></name><name><surname>Albright</surname><given-names>AL</given-names></name><name><surname>Apovian</surname><given-names>CM</given-names></name><name><surname>Clark</surname><given-names>NG</given-names></name><name><surname>Franz</surname><given-names>MJ</given-names></name><name><surname>Hoogwerf</surname><given-names>BJ</given-names></name><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Mayer-Davis</surname><given-names>E</given-names></name><name><surname>Mooradian</surname><given-names>AD</given-names></name><etal/><article-title>Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><issue>Suppl 1</issue><fpage>S61</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">18165339</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Vieth</surname><given-names>R</given-names></name><name><surname>Bischoff-Ferrari</surname><given-names>H</given-names></name><name><surname>Boucher</surname><given-names>BJ</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name><name><surname>Garland</surname><given-names>CF</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name><name><surname>McGrath</surname><given-names>JJ</given-names></name><etal/><article-title>The urgent need to recommend an intake of vitamin D that is effective</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><issue>3</issue><fpage>649</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">17344484</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Hollis</surname><given-names>BW</given-names></name><article-title>Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><issue>2</issue><fpage>317</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">15671234</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>A</given-names></name><name><surname>Nambi</surname><given-names>SS</given-names></name><name><surname>Mather</surname><given-names>K</given-names></name><name><surname>Baron</surname><given-names>AD</given-names></name><name><surname>Follmann</surname><given-names>DA</given-names></name><name><surname>Sullivan</surname><given-names>G</given-names></name><name><surname>Quon</surname><given-names>MJ</given-names></name><article-title>Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans</article-title><source>J Clin Endocrinol Metab</source><year>2000</year><volume>85</volume><issue>7</issue><fpage>2402</fpage><lpage>2410</lpage><pub-id pub-id-type="doi">10.1210/jc.85.7.2402</pub-id><pub-id pub-id-type="pmid">10902785</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Neyestani</surname><given-names>TR</given-names></name><name><surname>Gharavi</surname><given-names>A</given-names></name><name><surname>Kalayi</surname><given-names>A</given-names></name><article-title>Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status</article-title><source>Int J Vitam Nutr Res</source><year>2007</year><volume>77</volume><issue>5</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1024/0300-9831.77.5.341</pub-id><pub-id pub-id-type="pmid">18453319</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Neyestani</surname><given-names>TR</given-names></name><name><surname>Fereydouni</surname><given-names>Z</given-names></name><name><surname>Hejazi</surname><given-names>S</given-names></name><name><surname>Salehi-Nasab</surname><given-names>F</given-names></name><name><surname>Nateghifard</surname><given-names>F</given-names></name><name><surname>Maddah</surname><given-names>M</given-names></name><name><surname>Karandish</surname><given-names>M</given-names></name><article-title>Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2007</year><volume>45</volume><issue>1</issue><fpage>141</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1097/MPG.0b013e31804c5047</pub-id><pub-id pub-id-type="pmid">17592383</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Satoh</surname><given-names>K</given-names></name><article-title>Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method</article-title><source>Clin Chim Acta</source><year>1978</year><volume>90</volume><issue>1</issue><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/0009-8981(78)90081-5</pub-id><pub-id pub-id-type="pmid">719890</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Neyestani</surname><given-names>TR</given-names></name><name><surname>Shariatzadeh</surname><given-names>N</given-names></name><name><surname>Gharavi</surname><given-names>A</given-names></name><name><surname>Kalayi</surname><given-names>A</given-names></name><name><surname>Khalaji</surname><given-names>N</given-names></name><article-title>Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications</article-title><source>J Endocrinol Invest</source><year>2007</year><volume>30</volume><issue>10</issue><fpage>833</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">18075285</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Neyestani</surname><given-names>TR</given-names></name><name><surname>Gharavi</surname><given-names>A</given-names></name><name><surname>Kalayi</surname><given-names>A</given-names></name><article-title>Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions</article-title><source>Int J Food Sci Nutr</source><year>2009</year><volume>60</volume><issue>Suppl 1</issue><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">18686109</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>HW</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>FH</given-names></name><name><surname>Deng</surname><given-names>HY</given-names></name><name><surname>Conway</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>HT</given-names></name><name><surname>Recker</surname><given-names>RR</given-names></name><article-title>Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density</article-title><source>J Bone Miner Res</source><year>2002</year><volume>17</volume><issue>4</issue><fpage>678</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2002.17.4.678</pub-id><pub-id pub-id-type="pmid">11918225</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Ye</surname><given-names>WZ</given-names></name><name><surname>Reis</surname><given-names>AF</given-names></name><name><surname>Velho</surname><given-names>G</given-names></name><article-title>Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene</article-title><source>J Hum Genet</source><year>2000</year><volume>45</volume><issue>1</issue><fpage>56</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/s100380050011</pub-id><pub-id pub-id-type="pmid">10697965</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>PY</given-names></name><name><surname>Zhang</surname><given-names>YY</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>JR</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>LJ</given-names></name><name><surname>Xu</surname><given-names>FH</given-names></name><name><surname>Xiao</surname><given-names>P</given-names></name><name><surname>Xiong</surname><given-names>DH</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><etal/><article-title>A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases</article-title><source>J Med Genet</source><year>2005</year><volume>42</volume><issue>3</issue><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1136/jmg.2004.024752</pub-id><pub-id pub-id-type="pmid">15744035</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><article-title>WHAP: haplotype-based association analysis</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><issue>2</issue><fpage>255</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl580</pub-id><pub-id pub-id-type="pmid">17118959</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Bonjour</surname><given-names>JP</given-names></name><name><surname>Benoit</surname><given-names>V</given-names></name><name><surname>Pourchaire</surname><given-names>O</given-names></name><name><surname>Ferry</surname><given-names>M</given-names></name><name><surname>Rousseau</surname><given-names>B</given-names></name><name><surname>Souberbielle</surname><given-names>JC</given-names></name><article-title>Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women</article-title><source>Br J Nutr</source><year>2009</year><volume>102</volume><issue>7</issue><fpage>962</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1017/S0007114509371743</pub-id><pub-id pub-id-type="pmid">19519975</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Mistry</surname><given-names>VV</given-names></name><name><surname>Vukovich</surname><given-names>MD</given-names></name><name><surname>Hogie-Lorenzen</surname><given-names>T</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Specker</surname><given-names>BL</given-names></name><article-title>Bioavailability of vitamin D from fortified process cheese and effects on vitamin D status in the elderly</article-title><source>J Dairy Sci</source><year>2005</year><volume>88</volume><issue>7</issue><fpage>2295</fpage><lpage>2301</lpage><pub-id pub-id-type="doi">10.3168/jds.S0022-0302(05)72907-6</pub-id><pub-id pub-id-type="pmid">15956292</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Arabi</surname><given-names>A</given-names></name><name><surname>Zahed</surname><given-names>L</given-names></name><name><surname>Mahfoud</surname><given-names>Z</given-names></name><name><surname>El-Onsi</surname><given-names>L</given-names></name><name><surname>Nabulsi</surname><given-names>M</given-names></name><name><surname>Maalouf</surname><given-names>J</given-names></name><name><surname>Fuleihan Gel</surname><given-names>H</given-names></name><article-title>Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls</article-title><source>Bone</source><year>2009</year><volume>45</volume><issue>6</issue><fpage>1091</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2009.07.074</pub-id><pub-id pub-id-type="pmid">19647104</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Yun</surname><given-names>F</given-names></name><name><surname>Oczak</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>BY</given-names></name><name><surname>Vieth</surname><given-names>R</given-names></name><name><surname>Cole</surname><given-names>DE</given-names></name><article-title>Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation</article-title><source>Clin Biochem</source><year>2009</year><volume>42</volume><issue>10-11</issue><fpage>1174</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2009.03.008</pub-id><pub-id pub-id-type="pmid">19302999</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Lagunova</surname><given-names>Z</given-names></name><name><surname>Porojnicu</surname><given-names>AC</given-names></name><name><surname>Lindberg</surname><given-names>F</given-names></name><name><surname>Hexeberg</surname><given-names>S</given-names></name><name><surname>Moan</surname><given-names>J</given-names></name><article-title>The dependency of vitamin D status on body mass index, gender, age and season</article-title><source>Anticancer Res</source><year>2009</year><volume>29</volume><issue>9</issue><fpage>3713</fpage><lpage>3720</lpage><pub-id pub-id-type="pmid">19667169</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Hashemipour</surname><given-names>S</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name><name><surname>Adibi</surname><given-names>H</given-names></name><name><surname>Javadi</surname><given-names>E</given-names></name><name><surname>Sedaghat</surname><given-names>M</given-names></name><name><surname>Pajouhi</surname><given-names>M</given-names></name><name><surname>Soltani</surname><given-names>A</given-names></name><name><surname>Shafaei</surname><given-names>AR</given-names></name><name><surname>Hamidi</surname><given-names>Z</given-names></name><name><surname>Fard</surname><given-names>AR</given-names></name><etal/><article-title>Vitamin D deficiency and causative factors in the population of Tehran</article-title><source>BMC Public Health</source><year>2004</year><volume>4</volume><fpage>38</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-4-38</pub-id><pub-id pub-id-type="pmid">15327695</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Clements</surname><given-names>MR</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Hayes</surname><given-names>ME</given-names></name><name><surname>Hickey</surname><given-names>CD</given-names></name><name><surname>Lumb</surname><given-names>GA</given-names></name><name><surname>Mawer</surname><given-names>EB</given-names></name><name><surname>Adams</surname><given-names>PH</given-names></name><article-title>The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency</article-title><source>Clin Endocrinol (Oxf)</source><year>1992</year><volume>37</volume><issue>1</issue><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.1992.tb02278.x</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Vieth</surname><given-names>R</given-names></name><article-title>Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety</article-title><source>Am J Clin Nutr</source><year>1999</year><volume>69</volume><issue>5</issue><fpage>842</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">10232622</pub-id></mixed-citation></ref></ref-list></back></article>